Your browser doesn't support javascript.
Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort.
Horberg, Michael A; Watson, Eric; Bhatia, Mamta; Jefferson, Celeena; Certa, Julia M; Kim, Seohyun; Fathi, Lily; Althoff, Keri N; Williams, Carolyn; Moore, Richard.
  • Horberg MA; Kaiser Permanente Mid-Atlantic Permanente Medical Group, Mid-Atlantic Permanente Research Institute, Rockville, MD, 20852, USA. Michael.Horberg@kp.org.
  • Watson E; Kaiser Permanente Mid-Atlantic Permanente Medical Group, Mid-Atlantic Permanente Research Institute, Rockville, MD, 20852, USA.
  • Bhatia M; Kaiser Permanente Mid-Atlantic Permanente Medical Group, Mid-Atlantic Permanente Research Institute, Rockville, MD, 20852, USA.
  • Jefferson C; Kaiser Permanente Mid-Atlantic Permanente Medical Group, Mid-Atlantic Permanente Research Institute, Rockville, MD, 20852, USA.
  • Certa JM; United Health Group, Frederick, MD, 21703, USA.
  • Kim S; Kaiser Permanente Mid-Atlantic Permanente Medical Group, Mid-Atlantic Permanente Research Institute, Rockville, MD, 20852, USA.
  • Fathi L; Kaiser Permanente Mid-Atlantic Permanente Medical Group, Mid-Atlantic Permanente Research Institute, Rockville, MD, 20852, USA.
  • Althoff KN; Johns Hopkins University, Baltimore, MD, 21205, USA.
  • Williams C; National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, MD, 20892, USA.
  • Moore R; Johns Hopkins University, Baltimore, MD, 21205, USA.
Nat Commun ; 13(1): 5822, 2022 10 12.
Article in English | MEDLINE | ID: covidwho-2062206
ABSTRACT
Disease characterization of Post-Acute Sequelae of SARS-CoV-2 (PASC) does not account for pre-existing conditions and time course of incidence. We utilized longitudinal data and matching to a COVID PCR-negative population to discriminate PASC conditions over time within our patient population during 2020. Clinical Classification Software was used to identify PASC condition groupings. Conditions were specified acute and persistent (occurring 0-30 days post COVID PCR and persisted 30-120 days post-test) or late (occurring initially 30-120 days post-test). We matched 31 COVID PCR-negative COVIDPCR-positive by age, sex, testing month and service area, controlling for pre-existing conditions up to four years prior; 28,118 PCR-positive to 70,293 PCR-negative patients resulted. We estimated PASC risk from the matched cohort. Risk of any PASC condition was 12% greater for PCR-positive patients in the late period with a significantly higher risk of anosmia, cardiac dysrhythmia, diabetes, genitourinary disorders, malaise, and nonspecific chest pain. Our findings contribute to a more refined PASC definition which can enhance clinical care.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-33573-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-33573-6